Folgen
Caglar Cekic, Ph.D.
Caglar Cekic, Ph.D.
Novartis Institutes for BioMedical Research
Bestätigte E-Mail-Adresse bei novartis.com
Titel
Zitiert von
Zitiert von
Jahr
The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4
V Mata-Haro, C Cekic, M Martin, PM Chilton, CR Casella, TC Mitchell
Science 316 (5831), 1628-1632, 2007
10242007
Purinergic regulation of the immune system
C Cekic, J Linden
Nature Reviews Immunology 16 (3), 177-192, 2016
7702016
Patrolling monocytes control tumor metastasis to the lung
RN Hanna, C Cekic, D Sag, R Tacke, GD Thomas, H Nowyhed, E Herrley, ...
Science 350 (6263), 985-990, 2015
4692015
Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment
C Cekic, YJ Day, D Sag, J Linden
Cancer research 74 (24), 7250-7259, 2014
2932014
Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors
C Cekic, D Sag, Y Li, D Theodorescu, RM Strieter, J Linden
The Journal of Immunology, 2012
2282012
Regulation of lymphocyte function by adenosine
J Linden, C Cekic
Arteriosclerosis, thrombosis, and vascular biology 32 (9), 2097-2103, 2012
1792012
The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity
D Sag, C Cekic, R Wu, J Linden, CC Hedrick
Nature communications 6 (1), 6354, 2015
1762015
Adenosine A2A Receptors Intrinsically Regulate CD8+ T Cells in the Tumor Microenvironment
C Cekic, J Linden
Cancer research 74 (24), 7239-7249, 2014
1722014
Extracellular adenosine regulates naive T cell development and peripheral maintenance
C Cekic, D Sag, YJ Day, J Linden
Journal of Experimental Medicine 210 (12), 2693-2706, 2013
1242013
Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A
C Cekic, CR Casella, CA Eaves, A Matsuzawa, H Ichijo, TC Mitchell
Journal of Biological Chemistry 284 (46), 31982-31991, 2009
1152009
IFN-β production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-β
H Wang, CA Garcia, K Rehani, C Cekic, P Alard, DF Kinane, T Mitchell, ...
The Journal of Immunology 181 (10), 6797-6802, 2008
952008
The Expression of Adenosine A2B Receptor on Antigen-Presenting Cells Suppresses CD8+ T-cell Responses and Promotes Tumor Growth
S Chen, I Akdemir, J Fan, J Linden, B Zhang, C Cekic
Cancer immunology research 8 (8), 1064-1074, 2020
512020
Reactivation of cAMP pathway by PDE4D inhibition represents a novel druggable axis for overcoming tamoxifen resistance in ER-positive breast cancer
RR Mishra, N Belder, SA Ansari, M Kayhan, H Bal, U Raza, PG Ersan, ...
Clinical Cancer Research 24 (8), 1987-2001, 2018
472018
MyD88-dependent SHIP1 regulates proinflammatory signaling pathways in dendritic cells after monophosphoryl lipid A stimulation of TLR4
C Cekic, CR Casella, D Sag, F Antignano, J Kolb, J Suttles, MR Hughes, ...
The Journal of Immunology 186 (7), 3858-3865, 2011
472011
Adenosine receptor signaling targets both PKA and Epac pathways to polarize dendritic cells to a suppressive phenotype
M Kayhan, A Koyas, I Akdemir, AC Savas, C Cekic
The Journal of Immunology 203 (12), 3247-3255, 2019
302019
Targeting adenosine with adenosine deaminase 2 to inhibit growth of solid tumors
L Wang, LM Londono, J Cowell, O Saatci, M Aras, PG Ersan, S Serra, ...
Cancer Research 81 (12), 3319-3332, 2021
202021
Interleukin-7 protects CD8+ T cells from adenosine-mediated immunosuppression
A Koyas, S Tucer, M Kayhan, AC Savas, I Akdemir, C Cekic
Science Signaling 14 (674), eabb1269, 2021
162021
Ecto-5′-Nucleotidase (CD73) Regulates the Survival of CD8+ T Cells
MV Rosemblatt, B Parra-Tello, P Briceño, E Rivas-Yáñez, S Tucer, ...
Frontiers in Cell and Developmental Biology 9, 647058, 2021
82021
Modulation of myeloid cells by adenosine signaling
C Cekic
Current Opinion in Pharmacology 53, 134-145, 2020
42020
Methods and compositions for treating cancer
TVK George A. Gaitanaris, Marc A. Gavin, Robert H. LEMUS, Caglar CEKIC ...
WO Patent WO2023039578A1, 2023
2023
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20